Release Date: 12/01/17 09:10 Summary: Niuminco completes $600,000 Placement Price Sensitive: Yes Download Document 92.87KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%